Rosalin Arends

1.4k total citations
22 papers, 1.0k citations indexed

About

Rosalin Arends is a scholar working on Oncology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Rosalin Arends has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pharmacology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Rosalin Arends's work include Osteoarthritis Treatment and Mechanisms (4 papers), Inflammatory mediators and NSAID effects (4 papers) and HER2/EGFR in Cancer Research (4 papers). Rosalin Arends is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (4 papers), Inflammatory mediators and NSAID effects (4 papers) and HER2/EGFR in Cancer Research (4 papers). Rosalin Arends collaborates with scholars based in United States, United Kingdom and Netherlands. Rosalin Arends's co-authors include Danny D. Shen, W. Ummenhofer, Christopher M. Bernards, Pamela Lockbaum, Robert A. Figlin, Gisela Schwab, Eric K. Rowinsky, John A. Thompson, Ronald M. Bukowski and Jared Gollob and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Analytical Chemistry.

In The Last Decade

Rosalin Arends

21 papers receiving 975 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosalin Arends United States 14 358 238 214 201 139 22 1.0k
Ivo W. Tremont‐Lukats United States 15 204 0.6× 274 1.2× 192 0.9× 365 1.8× 111 0.8× 42 1.3k
Shefali Agarwal United States 20 412 1.2× 130 0.5× 230 1.1× 146 0.7× 121 0.9× 48 1.2k
Masato Narita Japan 22 329 0.9× 360 1.5× 334 1.6× 145 0.7× 24 0.2× 74 1.4k
Smita Kshirsagar United States 11 160 0.4× 167 0.7× 431 2.0× 68 0.3× 48 0.3× 17 968
Marc Hattenberger Switzerland 7 139 0.4× 85 0.4× 195 0.9× 82 0.4× 63 0.5× 7 550
Alexander Fisher United States 18 381 1.1× 221 0.9× 342 1.6× 99 0.5× 110 0.8× 39 1.1k
Suna Barlas United States 10 164 0.5× 123 0.5× 205 1.0× 97 0.5× 84 0.6× 13 845
Niels F. Jensen United States 18 118 0.3× 204 0.9× 345 1.6× 140 0.7× 34 0.2× 34 784
Keon Uk Park South Korea 21 666 1.9× 292 1.2× 400 1.9× 612 3.0× 32 0.2× 84 1.4k
Jonathan Bleeker United States 12 1.5k 4.3× 160 0.7× 213 1.0× 384 1.9× 71 0.5× 35 2.0k

Countries citing papers authored by Rosalin Arends

Since Specialization
Citations

This map shows the geographic impact of Rosalin Arends's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosalin Arends with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosalin Arends more than expected).

Fields of papers citing papers by Rosalin Arends

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosalin Arends. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosalin Arends. The network helps show where Rosalin Arends may publish in the future.

Co-authorship network of co-authors of Rosalin Arends

This figure shows the co-authorship network connecting the top 25 collaborators of Rosalin Arends. A scholar is included among the top collaborators of Rosalin Arends based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosalin Arends. Rosalin Arends is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ignacio, Rachel Bender, David A. Wohl, Rosalin Arends, et al.. (2022). Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS‐CoV‐2 Infection. Clinical Pharmacology & Therapeutics. 112(6). 1207–1213. 8 indexed citations
3.
Petrone, Marcella, et al.. (2021). A novel integrated QSP model of in vivo human glucose regulation to support the development of a glucagon/GLP‐1 dual agonist. CPT Pharmacometrics & Systems Pharmacology. 11(3). 302–317. 7 indexed citations
4.
Karsdal, M.A., Kenneth M. Verburg, Christine R. West, et al.. (2018). Serological biomarker profiles of rapidly progressive osteoarthritis in tanezumab-treated patients. Osteoarthritis and Cartilage. 27(3). 484–492. 18 indexed citations
5.
Arends, Rosalin, M.A. Karsdal, Kenneth M. Verburg, et al.. (2017). Identification of serological biomarker profiles associated with total joint replacement in osteoarthritis patients. Osteoarthritis and Cartilage. 25(6). 866–877. 19 indexed citations
6.
Arends, Rosalin, et al.. (2016). Biomarkers associated with rapid cartilage loss and bone destruction in osteoarthritis patients. Osteoarthritis and Cartilage. 24. S53–S53. 1 indexed citations
7.
Jonsson, E. Niclas, Rujia Xie, Scott Marshall, & Rosalin Arends. (2015). Population pharmacokinetics of tanezumab in phase 3 clinical trials for osteoarthritis pain. British Journal of Clinical Pharmacology. 81(4). 688–699. 19 indexed citations
8.
Winter, Helen, Rosalin Arends, Gary W. Jay, et al.. (2011). Assessment of the pharmacology and tolerability of PF‐04457845, an irreversible inhibitor of fatty acid amide hydrolase‐1, in healthy subjects. British Journal of Clinical Pharmacology. 73(5). 706–716. 104 indexed citations
9.
Yang, Bingbing, et al.. (2010). Pharmacokinetic and Pharmacodynamic Perspectives on the Clinical Drug Development of Panitumumab. Clinical Pharmacokinetics. 49(11). 729–740. 50 indexed citations
10.
Arends, Rosalin, et al.. (2009). Preliminary Pharmacokinetic/Pharmacodynamic (PK/PD) Analysis for the Effect of Tanezumab on Overall Daily Pain Score Data in Adults with Moderate-to-Severe Pain due to Osteoarthritis of the Knee. 3 indexed citations
11.
Weiner, Louis M., Arie S. Belldegrun, Jeffrey Crawford, et al.. (2008). Dose and Schedule Study of Panitumumab Monotherapy in Patients with Advanced Solid Malignancies. Clinical Cancer Research. 14(2). 502–508. 95 indexed citations
12.
Arends, Rosalin, et al.. (2005). Flexible dosing schedules of panitumumab (ABX-EGF) in cancer patients. Journal of Clinical Oncology. 23(16_suppl). 3089–3089. 15 indexed citations
13.
14.
Rowinsky, Eric K., Garry Schwartz, Jared Gollob, et al.. (2004). Safety, Pharmacokinetics, and Activity of ABX-EGF, a Fully Human Anti–Epidermal Growth Factor Receptor Monoclonal Antibody in Patients With Metastatic Renal Cell Cancer. Journal of Clinical Oncology. 22(15). 3003–3015. 243 indexed citations
15.
Ummenhofer, W., Rosalin Arends, Danny D. Shen, & Christopher M. Bernards. (2000). Comparative Spinal Distribution and Clearance Kinetics of Intrathecally Administered Morphine, Fentanyl, Alfentanil, and Sufentanil. Anesthesiology. 92(3). 739–753. 219 indexed citations
16.
Arends, Rosalin, et al.. (1999). Optimal Propofol-Alfentanil Combinations for Supplementing Nitrous Oxide for Outpatient Surgery . Anesthesiology. 91(1). 97–108. 6 indexed citations
17.
Arends, Rosalin, Takahiko Hayashi, Thomas J. Luger, & Danny D. Shen. (1998). Cotreatment with Racemic Fenfluramine Inhibits the Development of Tolerance to Morphine Analgesia in Rats. Journal of Pharmacology and Experimental Therapeutics. 286(2). 585–592. 23 indexed citations
18.
Arends, Rosalin, et al.. (1997). Pharmacokinetic-pharmacodynamic correlation of ibuprofen analgesia Comparison between ibuprofen arginate and motrin IB. Clinical Pharmacology & Therapeutics. 61(2). 199. 2 indexed citations
19.
Arends, Rosalin, et al.. (1996). Pharmacokinetic/pharmacodynamic relationship of benzodiazepines in the direct cortical stimulation model of anticonvulsant effect.. Journal of Pharmacology and Experimental Therapeutics. 279(2). 803–812. 29 indexed citations
20.
Arends, Rosalin, et al.. (1994). Stereoselective pharmacokinetics of stiripentol: an explanation for the development of tolerance to anticonvulsant effect. Epilepsy Research. 18(2). 91–96. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivo W. Tremont‐Lukats Breakdown of academic impact, for papers by Shefali Agarwal Breakdown of academic impact, for papers by Masato Narita Breakdown of academic impact, for papers by Smita Kshirsagar Breakdown of academic impact, for papers by Marc Hattenberger Breakdown of academic impact, for papers by Alexander Fisher Breakdown of academic impact, for papers by Suna Barlas Breakdown of academic impact, for papers by Niels F. Jensen Breakdown of academic impact, for papers by Keon Uk Park Breakdown of academic impact, for papers by Jonathan Bleeker
Rankless by CCL
2026